source
- Novo Nordisk Indiana plant faces FDA re-inspection after hair found in drugs and roof leaks threaten sterilityNovo Nordisk's fill‑finish facility in Bloomington, Indiana underwent a follow‑up FDA inspection in April. The agency reported mammalian hair in finished drug containers and identified water leaks…
- Otsuka presents new data to bolster full approval bid for Voyxact in IgA nephropathyOtsuka Pharmaceutical announced that new clinical evidence has been generated for its monoclonal antibody Voyxact, aimed at treating IgA nephropathy, a chronic autoimmune kidney disease. The data,…